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ABSTRACT (275 words)  
Background: There is increasing recognition of the importance of addressing low health literacy 
in patient decision aid (PtDA) development.  
Purpose: An updated review as part of IPDAS 2.0 examined the extent to which PtDAs are 
designed to meet the needs of low health literacy/disadvantaged populations and their impact 
on decision-making and health outcomes. 
Data Sources: Reference list of Cochrane review of randomised controlled trials (RCTs) of PtDAs 
(2014, 2017 and upcoming 2020 versions). 
Study Selection: RCTs that assessed the impact of PtDAs on low health literacy or other 
disadvantaged groups (i.e. ≥50% participants from disadvantaged groups and/or subgroup 
analysis in disadvantaged group/s). 
Data Extraction: Two researchers independently extracted data into a standardized form 
including PtDA development details, decision-making and health outcomes. We searched online 
repositories and emailed authors to access PtDAs to verify reading level. 
Data Synthesis: Twenty-five out of 213 RCTs met inclusion criteria illustrating only 12% of 
studies addressed the needs of low literacy/disadvantaged populations. Only seven (28%) 
calculated a reading age (recommended in previous IPDAS guidelines) and none met guidance 
for low literacy populations. We pooled outcomes in the meta-analysis using random effects 
models and assessed heterogeneity using I2. PtDAs improved knowledge (mean 
difference(MD)=14.65, 95% confidence interval (CI):9.48,19.83, I2=96%) and patient-clinician 
communication (risk ratio (RR)=1.62, 95%CI:1.42,1.84, I2=0%), and reduced decisional conflict 
(MD=-4.15, 95%CI:-7.38,-0.93, I2=81%) and proportion undecided (RR=0.23, 95%CI:0.11,0.50, 
I2=66%).  
Limitations: The source of heterogeneity was not assessed due to expected variable contexts 
and outcomes. Results should be interpreted considering this limitation. 
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Conclusions: Only 12% of PtDA studies addressed disadvantaged groups. Greater attention to 
health literacy and disadvantaged populations is needed in the field of PtDAs to ensure equity 





Health literacy is defined as people’s knowledge, motivation and competences to access, 
understand, appraise, and apply health information in order to make judgments and decisions, 
and act upon their decision in everyday life concerning healthcare, disease prevention and 
health promotion.1 Low health literacy is prevalent in many countries including those with high 
incomes, for example, estimates range between 1/3 and ½ population have basic or inadequate 
literacy depending on the measure used in countries such as US, UK and Australia). Despite this, 
few patient decision aids (PtDAs) address the needs of adults with lower health literacy. In a 
2013 review of 97 trials, only three PtDAs overtly addressed the needs of lower health literacy 
users.2 In 90% of trials, user health literacy and readability of the PtDAs were not reported.2  
There has been increasing international recognition of the importance of addressing the needs 
of patients and consumers with low health literacy when developing shared decision-making 
tools.3 The original International Patient Decision Aid Standards (IPDAS) quality criteria 
checklist, for example, included three criteria pertaining to the use of ‘plain language’ (see Box 
1).1  Although this was reduced to one item in the 2009 (IPDASi v3.0) and 2013 (IPDASi v4.0) 
revisions of the standards (“The decision support technology (or associated documentation) 
reports readability levels (using one or more of the available scales)) several shared decision-
making tools designed since then have been guided by this criterion. 
 
1 a) Is written at a level that can be understood by the majority of patients in the target group; b) Is written at a 
Grade 8 equivalent level or less according to readability score [SMOG or FRY]; c) Provides ways to help patients 




Box 1. IPDAS criteria pertaining to the use of ‘plain language’ 
Evidence reviews show that the comprehension of health information among individuals with 
low health literacy can be improved through modifications to communication and other mixed-
strategy interventions 4,5 . For example, two systematic reviews (and the individual projects that 
they draw upon) highlight benefits of reducing medical jargon and presenting essential 
information only (or first) in materials for adults with lower health literacy, as well as the 
potential utility of different communication formats (e.g., illustrated text; spoken animations; 
pictorial information).4,5 There has also been growing movement towards, and evidence-base 
for, consumer involvement in the development and review of patient information materials.6 
However, it is unclear the extent to which new evidence and recommendations related to 
health literacy have been implemented in the development and evaluation of PtDAs since 2013, 
and its impact on decision making and health outcomes.  
Aims 
This systematic review is an update of our previous 2013 review of the evidence relating to 
health literacy and PtDAs for IPDAS 2.0. We aimed to examine the extent to which PtDAs had 
been designed and tested on lower health literacy and disadvantaged populations and if so, to 
understand their impact on decision making and health outcomes.  
Review questions 
IPDAS quality criteria checklist (2005)  
 Is written at a level that can be understood by the majority of 
patients in the target group 10.3 
 Is written at a grade 8 equivalent or less according to readability 
score (SMOG or FRY) 10.4 
 Provides ways to help patients understand information other than 
reading [audio, video, in-person discussion] 10.5 
IPDAS instrument (IPDASi v3.0) (2009) and IPDAS minimal criteria (IPDASi 
v4.0) (2013) 
 The decision support technology reports readability levels (using one 
or more of the available scales). 3.06 
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We reviewed literature on PtDAs to understand the extent to which they have been tailored to 
low health literacy and other disadvantaged groups. Our research questions are summarized 
below: 
1. In the randomized trials studying PtDAs’ effectiveness, to what extent are low health 
literacy and other disadvantaged groups considered in the development and 
evaluation of PtDAs? 
a. What proportion of PtDAs have considered low health literacy and other 
disadvantaged groups in their development and/or evaluation? 
b. How have these PtDAs been tailored for adults with low health literacy and other 
disadvantaged groups? 
c. What are the readability and cognitive demand scores of the PtDAs tailored for 
adults with low health literacy and other disadvantaged groups?  
2. What is the impact of tailored PtDAs for adults with low health literacy and other 
disadvantaged groups on decision making and health outcomes? 
METHODS 
Protocol and registration  
The aims and methods for this systematic review were registered on Prospero (Registration 
number CRD42019159042). Reporting is guided by the Preferred Reporting Items for 
Systematic Reviews (PRISMA) checklist 7. 
Information sources and search strategy  
We searched for published trials of PtDAs in the 2014, 2017 and 2020 versions of the Cochrane 
systematic review of randomized controlled trials (RCTs) of PtDAs.2 This series of Cochrane 
reviews aim to examine the effects of PtDAs for individuals who are making treatment or 
screening decisions (aged 18+, making decisions for themselves, a child, or an incapacitated 
significant other). Their scope covers all published RCTs that compare the effects of PtDAs on 
decision-making outcomes (e.g., knowledge, risk perceptions and involvement in decision 
 
2 We include studies from 2014 onwards because 28 studies were excluded from the 2017 review. We also include 
studies from the unpublished 2020 review to ensure more recent RCTs were included. 
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making) relative to some alternative ‘usual care’ (e.g., general information, clinical practice 
guideline, placebo, no intervention).8,9 PtDAs are defined as “evidence-based tools designed to 
help patients make specific and deliberated choices among healthcare options” (p. 7) 9. 
Eligibility criteria 
To be included in the current systematic review, studies had to include at least 50% of 
participants from disadvantaged groups and/or conduct a separate analysis exploring the 
impact of the PtDA on disadvantaged groups. Disadvantaged groups were defined using the 
following eight criteria, based on previous work by Durand et al 10: 
1. People who have lower literacy and/or lower health literacy 
2. People who have lower educational attainment 
3. People who are socially disadvantaged with respect to poverty or lower socioeconomic 
status 
4. People who are socially disadvantaged as a result of their ethnicity or race 
5. People who are socially disadvantaged with respect to geographical location (areas 
described as disadvantaged/or medically underserved) 
6. People who are uninsured or on public health insurance 
7. People who have lower numeracy 
8. People who are socially disadvantaged as a result of speaking a primary language that 
differs from the official language(s) of their country of residence. 
All conditions and clinical settings (e.g., lay care, primary care, secondary/tertiary care) were 
included. 
Screening and study selection  
Articles were independently screened in two stages by JS and OM as follows: screening of titles 
and abstracts followed by the retrieval and screening of relevant full-text articles using the 
inclusion criteria described above. Disagreements were resolved through discussion, or with the 
help of a third reviewer (DM). 
Data extraction and risk of bias assessment 
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We used a standardized form to extract relevant data, which was pilot tested and iteratively 
revised. Of nine researchers (DM, JS, OM, KM, TC, AG, AL, AH, SS), two were assigned to each 
study to independently extract data including the methodology of each study, the development 
and/or evaluation of the PtDAs and the outcomes of the RCT. Data items extracted relating to 
each research question are presented in Table 1. 
Risk of bias assessments were not conducted for studies that had already been assessed as part 
of the Cochrane Review (2014 and 2017 versions). Recent studies that had not yet been 
assessed for the 2020 version of the Cochrane Review were assessed for risk of bias by two 
independent reviewers from the study team using the revised Cochrane tool.11 
Independent PtDA readability and cognitive demand assessment 
To access PtDAs not published with their corresponding articles, we searched the Decision Aid 
Inventory Library maintained by the Ottawa Hospital Research Institute.12 If the PtDA was not 
publicly available, we made two email attempts via the corresponding authors’ emails specified 
on the manuscript.  
Data synthesis and analysis 
We pooled data for outcomes in a meta-analysis if they were reported at least three times 
across the included studies and used similar and comparable measures to assess the same 
construct (Revman 5.3). For continuous outcomes assessed on different scales, we standardized 
scores to range from 0 to 100 points to facilitate the pooling of data. We used a random-effects 
model because of the diversity of the included studies and the anticipated variability in 
populations and PtDAs. Where studies included more than two groups, we analyzed those that 
aligned more closely with a control and PtDA. We pooled continuous outcomes based on the 
mean, standard deviation (SD) and number of people assessed for the PtDA and control groups 
to calculate mean difference (MD) and 95% confidence interval (CI). When measures were 
repeated, we selected the time point that reported the most conservative estimate. We 
calculated a relative risk for outcomes reported as proportions using percentage and number of 
people assessed in each group.  
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Outcomes that could not be pooled in a meta-analysis were synthesized using narrative 
synthesis. We reported means or percentages for each outcome for each group in trials 
including ≥50% low health literacy or other disadvantaged population, and indicators of 
statistical significance (e.g., p-values). For studies that conducted subgroup analyses of 
disadvantaged groups, we similarly reported means or % for each outcome and performed 
narrative synthesis. 
Assessment of heterogeneity 
We anticipated there would be substantial heterogeneity in our pooled effect estimates due to 
the grouping of studies across different populations and contexts. As a result, we decided to 
consider the variability in direction of effects (rather than size of effects) to interpret 
heterogeneity. Therefore, we did not downgrade for inconsistency where the direction of effect 
was consistent across studies. 
Assessment of reporting biases 
We produced funnel plots for each outcome included in the meta-analysis to visually assess 
potential for publication bias.  
Subgroup and sensitivity analysis 
No subgroup or sensitivity analyses were pre-specified; however, one arose after extracting 
data. Decisional conflict was measured using two different versions of the Decisional Conflict 
Scale: the low-literacy 10-item version and the full 16-item version. Therefore, we conducted a 




Table 1. Data items for each research question. 
Research question  Data items, summary measures and synthesis approach 
1a. How many PtDAs 
considered low health 
literacy and other 
disadvantaged groups? 
Proportion of PtDAs included in the 2014, 2017 and 2020 versions of the Cochrane 
systematic review that consider low literacy and other disadvantaged groups in their 
development or evaluation as stated in the manuscript or determined by study 
participants or analyses. 
1b. How have these PtDAs 
been tailored for adults 
with low health literacy 
and other disadvantaged 
groups? 
Narrative description of how PtDAs meeting our inclusion criteria were developed or 
tailored for low literacy and other disadvantaged groups, including an inventory of the 
strategies used. 
1c. What are the 
readability and cognitive 
demand scores of the 
PtDAs tailored for adults 
with low health literacy 
and other disadvantaged 
groups?  
We reported the proportion of PtDAs that were written at a <8th grade level and < 6th 
grade. Grade reading level was calculated using the Online-Utility.org readability 
calculator.13 We average the SMOG and Gunning-Fog scores to provide an overall grade 
reading level for PtDAs we accessed. Video format PtDAs were transcribed verbatim to 
assess the readability of the transcript. Full text of the PtDAs were prepared in line with 
guidelines by removing text that is not in full sentences (i.e. titles, headings, 
subheadings, short captions), embedded punctuation, and document design elements 
(e.g., gaps, white spaces, pictures and images, and text boxes). Bulleted text was 
included if it was in a full sentence or could be adapted to form a full sentence (e.g., 
moving words from the stem into the list) and punctuated by adding a full stop. 
Footnotes were removed unless they were essential to understanding the main PtDA 
content.  
We reported the proportion of PtDAs that met the PEMAT criteria for >70% actionability 
and understandability. Understandability and actionability were calculated for each 
PtDA that we are able to access using the Patient Education Materials Assessment Tool 
(PEMAT; see Box 2) 14,15. 14,15. PEMAT scores were independently scored by two team 
members (JS and OM) and disagreements were resolved via discussion with a third.  
2. What is the impact of 
tailored PtDAs for adults 
with low health literacy 
and other disadvantaged 
groups on psychosocial 
and clinical outcomes? 
Psychosocial and clinical outcomes were extracted for each study: attributes of the 
choice made (knowledge, accurate risk perception, values-choice congruence), 
attributes of the decision-making process (decisional conflict, patient-clinician 
communication, participation in decision making, satisfaction), behavior (intentions and 
preferences, behavioral outcomes), health outcomes (anxiety, regret, confidence) and 









We analyzed 25 articles that met the inclusion criteria as they included at least 50% of 
participants from a disadvantaged population (n=10 studies), conducted a separate analysis 
including participants from a disadvantaged population (n=5), or did both (n=10; Table 2). 
(Figure 2). The total number of participants in all included trials was 9865. 
Most included studies evaluated unique PtDAs. Exceptions include two studies by 
Kuppermann et al.16,17 that evaluated the same PtDA titled ‘Prenatal testing: exploring your 
options’.  Three studies evaluated variations of a previously validated PtDA which included 
two videos18,19 and a computerized program titled ‘CHOICE’ (Communicating Health Options 
through Interactive Computer Education).20   
Studies were conducted in the United States (n=22), Australia (n=2) and England (n=1; see 
Table 2). Participants included people considering prostate-specific antigen testing for 
prostate cancer screening (n=6), colorectal cancer screening (n=8), people with 
osteoarthritis considering knee replacement (n=2), women with early stage breast cancer 
considering surgery options (n=2), men with prostate cancer deciding about treatment 
(n=1), and people with chest pain deciding to be admitted for further testing or followed-up 
(n=1). Participants also included those considering living donor kidney transplantation (n=1), 
prenatal genetic testing (n=2), diabetes screening (n=1), or early intervention for children 
Domain: Understandability (17 items P; 13 items AV)  
Assesses 6 topics/ domains: content, word choice and style, use of numbers, organisation, layout and design, 
use of visual aids. (see appendix for full list) 
Domain: Actionability (7 items P; 4 items AV) 
Item 20: The material clearly identifies at least one action the user can take (P and A/V) 
Item 21: The material addresses the user directly when describing actions (P and A/V) 
Item 22: The material breaks down any action into manageable, explicit steps (P and A/V) 
Item 23: The material provides a tangible tool whenever it could help the user take action (P) 
Item 24: The material provides simple instructions of how to perform calculations (P)  
Item 25: The material explains how to use charts, graphs, tables or diagrams to take actions (P and A/V) 
Item 26: The material uses visual aids whenever they could make it easier to act on instructions (P) 
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with developmental concerns (n=1). Characteristics of disadvantaged populations relative to 
the reasons for inclusion are shown in Table 2. 
Studies included participants from disadvantaged groups including at least 50% of the 
sample with lower literacy (n=3) or lower education (n=7), or who were socially 
disadvantaged with respect to poverty or socioeconomic status (n=6), ethnicity or race 
(n=16), geographical location (n=2), or insurance status (n=5). Two studies recruited 
socioeconomically disadvantaged participants by targeting particular postcodes.21,22 Three 
studies also implied that the majority of their sample included participants from 
disadvantaged groups as they recruited from disadvantaged geographical locations or sites 
that primarily serve disadvantaged groups.19,20,23 Studies that conducted separate analyses 
explored the moderating effects of literacy or health literacy (n=5), education (n=8), 
numeracy (n=1), poverty or socioeconomic status (e.g. income, n=2), ethnicity or race (n=5), 
geographical location (n=2), insurance status (n=3) or language preference (n=1) by 
including interactions. One study that conducted a separate analysis only restricted their 
analysis within the low-literacy group, but did not compare to a high literacy group 24 and 
another conducted a separate analysis to test the effect of their intervention among Latino 
participants only 18.  
Risk of bias  
Of the nine studies we assessed for risk of bias, four had unclear risk of bias overall 
(Appendix; Table 2). This was mainly due to concerns regarding deviations from the 
intended interventions (n=8), outcome measurement (n=4) and reporting results (n=5). 
These concerns typically arose because there was no blinding of participants or researchers 
delivering interventions, lack of information about blinding of outcome assessors or no 
evidence of planned analyses. Of the sixteen studies that were already assessed as part of 
the 2014 and 2017 versions of the Cochrane review (Appendix; Table 3), three had low risk 
of bias for all domains, but many had unclear risk of bias for allocation concealment (n=11), 
blinding of participants (n=9) and selective reporting (n=10).  
Assessment of reporting biases 
Lack of symmetry was observed when examining the funnel plot for decisional conflict 















Figure 2. Inclusion and exclusion of studies in 2014-2020 versions of the Cochrane review3  
 
* There is substantial overlap between the 2014 and 2017 reviews (n=87). The 2017 version included 18 new 
studies, but also excluded 28 previously included studies because they compared detailed and simple PtDAs.  
Studies included in 2014 
Cochrane Review (n=115) 
Studies included in 2017 
Cochrane Review (n = 105) 
Potential studies included in 
















(n = 182) 
Full-text articles 
assessed for eligibility 














(n = 213) 
Studies included  
(n = 25) 
Excluded, did not meet 
eligibility criteria (n = 6) 
Did not include >50% 
disadvantaged group or sub-
analysis 
Unique studies (n=115) Unique studies (n=18)* Unique studies (n=80) 
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Table 2. Characteristics of included studies (total participants in all trials = 9,865)  




















































































































 Target population 
Participants targeted for recruitment, as described 
by authors 
Basis on which population   
was classified to be within a 
disadvantaged group 
Context of decision 




92 ✓ ✓ ✓   ✓    
Patients who initiated hemodialysis within 2 years  
of screening, AA, English speaking, 18+ years 
59% ≤$20k income, 100% AA, 73% 
≤high school, 74% no private 
insurance 
Living donor kidney 
transplantation 





262  ✓    ✓   ✓ 
50-75 years, English or Spanish speaking, average 
risk, not up to date with recommended screening, 
had upcoming appointment 
61% Lat., 88% no private insurance. 
Separate analysis to test 
moderating effects of race, 
insurance, education, literacy, 
language and site 
CRC screening 
Diefenbach  
et al 2018 
USA 349         ✓ 
Patients with PCa (localized), not yet made a 
treatment decision, English-speaking, access to 
computer 
Separate analysis to test 
moderating effects of race and 
education 
PCa treatment 




88  ✓       ✓ 
49-75 years, AA, due for screening,  
English speaking 
100% AA. Separate analysis to test 
moderating effects of health 
literacy 
CRC screening 




336 ✓ ✓        
50+ years, AA, chronic and frequent knee pain, 
evidence of knee osteoarthritis  
50% annual household income 
<$15k, 100% AA 
Total knee replacement  






 ✓       ✓ 
English-speaking parents of children <36 months 
referred to early intervention for developmental 
concerns 
88% AA parents. Separate analysis 
of low health literacy group 
Early intervention for 
developmental 





138  ✓    ✓    
Women diagnosed with early stage BCa (I-IIIA), 
candidates for breast-conserving surgery 
38% AA, 45% Hisp., 100% 
uninsured 
BCT vs. mastectomy 
Kuppermann et 
al 2009 
California USA 496  ✓       ✓ 
Pregnant women, ≤20 weeks gestation who have 
not undergone prenatal testing 
15.5% AA, 17.7% Lat., 13.3% Asian, 
5.6% Other. Separate analysis to 
test moderating effects of educ. 
and site 
Prenatal genetic testing 
Kuppermann et 
al 2014 
California USA 710 ✓ ✓   ✓     
Pregnant women, ≤20 weeks gestation who have 
not undergone prenatal testing 
45% Lat., 16% AA, 59% from sites 
serving women of low-SES  
Prenatal genetic testing 
Lepore et al 
2012 
Urban NE USA 490  ✓ ✓       
Men aged 45-70, of AA descent, without PCa 
diagnosis, or testing <12 months prior 
100% AA, 63% ≤ high school PSA testing for PCa 
15 
 
Marteau et  
al 2010 
England 1272         ✓ 
Men and women aged 40-69 at risk of  
type 2 diabetes 
Separate analysis to test 
moderating effects of SES  
Diabetes  
screening 




264 ✓ ✓ ✓ ✓ ✓    ✓ Age 50-74, due for screening, SES disadvantaged 
70% income <$20k, 73% AA, 67% 
≤high school, 56% limited health 
literacy. Separate analysis to test 
moderating effects of health 
literacy 
CRC screening 




450 ✓    ✓    ✓ 
Age 50-74, English-speaking, scheduled to see 
primary care physician, due for screening 
Separate analysis to test 
moderating effects of income, 
health literacy and race 
CRC screening 
Myers et al 
2005 
Urban-NE USA 242  ✓ ✓       Men, AA, 40-69, eligible for screening 100% AA, 61% ≤high school PSA testing 
Rising et al 
2017 
USA 898    ✓     ✓ 
Age 18+, presented to emergency with chest pain, 
negative cardiac workup, no ischemic ECG changes, 
cardiac troponin < upper limit of normal 
> 61% low health literacy. Separate 
analysis to test moderating effects 
of race, income, insurance, 
education, health literacy and 
numeracy 
Chest pain testing vs. 
observation and follow-
up 
Ruffin et al 
2007 
Midwest USA 174     ✓    ✓ Age 50-70, due for screening, no previous screening 
Separate analysis to test 
moderating effects of geographical 
location, insurance, education and 
race 
CRC screening 
Schroy et al 
2011 
Urban NE USA 666  ✓    ✓    Age 50-75, due for CRC screening 
63% AA, 6% Hisp., 66% Medicaid, 
Medicare, free care, or none 
CRC screening 
Smith et al 
2010 
NSW Australia 572 ✓  ✓       
Age 55-64, English-speaking, average or slightly 
above average risk of bowel cancer, low education 
59% 0-10 years in education Bowel cancer screening 




60         ✓ Females with stage I or II BCa  
Separate analysis to test 
moderating effects of education 
BCT vs. mastectomy 
Taylor et al 
2006 
USA 238  ✓        Men aged 40-70, no history of prostate cancer 
100% AA. Separate analysis to test 
moderating effects of education 
PCa screening 
Trevena et al 
2008 
Australia 314   ✓      ✓ Age 50-74, good English, no personal history of CRC 
78% <high school. Separate 
analysis to test moderating effects 
of education 
CRC screening 
Vina et al 2016 USA 493 ✓ ✓        
Age 50+ years, AA, chronic knee pain, evidence of 
knee osteoarthritis 
100% AA, 47% <$15k income Knee replacement 
Volk et al 2008 
Urban-Sth 
USA 
450         ✓ 
Male primary care patients, age 50-70 if not AA, 40-
70 if AA, no history of PCa 
Separate analysis to test 
moderating effects of low literacy  
PSA testing 




543  ✓       ✓ 
Men aged 40-70, no PCa history, pre-registered for 
screening >5 days in advance, English-speakers 
61% AA. Separate analysis to test 
moderating effects of race 
PSA testing 
Wolf et al 1996 
Urban/Rural 
NE/Sth USA 
205 ✓  ✓   ✓    Men ≥50 years, no PSA testing or PCa history 
65% income <$15k, 68% <high 
school, 59% public insurance 
PSA testing 




PtDA format and implementation 
Formats of PtDAs varied but were most commonly computerized or web-based multimedia 
programs that included audio, video and interactive learning modules (n=10 studies; Table 
3).16,17,19,20,23,25-29 Other formats included print (n=4),21,30-32 video (n=3)18,33,34 and audio (n=1).35 
Often interventions included a combination of formats such as print/video (n=3).22,36,37 Four 
studies used print/video with another element such as text messages,24 telephone38,39 or face-
to-face counselling.40 It was generally not specified whether a modality was chosen specifically 
to  accommodate users with low literacy, with the exception of two studies that reported using 
a touch screen PtDA format to this end.19,29 
Tailoring for adults with low health literacy and other disadvantaged groups 
Table 3 lists strategies for tailoring PtDAs to disadvantaged groups. In total, eight studies (33%) 
reported assessing readability to improve their PtDas, which represents the minimum 
requirement to meet IPDAS quality criteria. Seven studies (28%) reported designing their PtDA 
at a reading level of grade ≤8, four of which reported involvement of experts in either plain 
language, literacy, adult education or health communication.22,25,31,37 Readability analysis 
software was used in one study to refine the PtDA text,21 one study reported the text was 
written at reduced readability,38 and one study simply reported that the reading grade level 
was calculated, however it is not clear whether it was specifically designed to be below grade 
8.19 Four studies stated that IPDAS criteria were followed; three attended to the original IPDAS 
quality criteria checklist,24,32,37 while one attended to the IPDAS instrument (IPDASi v3.0) 
checklist.22 An additional study reported that the IPDAS guidelines contributed to the 
conceptual framework that guided PtDA development,33 and another updated their PtDA after 
the study was conducted to satisfy the original IPDAS quality criteria checklist.26 Eight studies 
reported using strategies to reduce cognitive burden including plain language, the use of a 
glossary of key terms, bullet points, visual cues and illustrations, narration, and simple 
navigation.22,24,26,27,32,33,36,39 Three studies used the Edutainment Decision Aid Model (EDAM) to 
guide development of PtDAs.26,27,33 This approach was initially developed in 2007 by Jibaja-
Weiss and Volk with the aim to make a PtDA both entertaining and educational for users with 
low-literacy by incorporating tailored soap opera scenes and linking them to interactive 
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learning modules.41 In the PtDAs that utilized EDAM, the characters in the soap opera episodes 
were tailored to the ethnicity/race and age of the user. 
Studies that used other methods of tailoring for disadvantaged groups are specified in Table 3. 
Of note, sixteen studies reported involvement of consumers, whereby two reported having a 
patient partner on the research team36,37 and fourteen involved patients/consumers in the 
development of the PtDA. Six reported conducting focus groups with patients,16-18,29,36,37 three 
reported conducting interviews with patients,20,22,39 and two reported conducting both focus 
groups and interviews.23,24 Thirteen studies reported conducting pilot, user or usability testing 
with target disadvantaged groups (Table 3). Five additional studies conducted a form of user 
testing but did not specify whether it was in disadvantaged groups.16,17,25,29,33 Communication 




Table 3. Methods used to tailor PtDAs for disadvantaged groups 
 






































































































































 Decision-aid format and strategy used to tailor it for low health literacy/disadvantaged 
group 




✓  ✓ ✓ ✓  ✓ 
1) PREPARED: 50-min DVD describing living donor kidney transplant and a 162-page book written at 
4th grade reading level summarizing the evidence about treatment effects on aspects of patients’ 
lives. Focus groups of patients, families, experts (clinicians, health education specialist, patient 
advocacy specialist, video scriptwriter, medical illustrator). Cognitive interviews with patients. Two 
pilot phases with 48 diverse patients.  
2) PREPARED PLUS: offered donors reimbursement along with PtDA video and book. 
Routine care in hemodialysis 
facilities. Participants in any 3 
groups could have received 
educational materials or financial 
assistance through usual care 
Brenner et al 
2016^# 
  ✓ ✓ ✓ ✓  
Video: Communicating Health Options through Interactive Computer Education (CHOICE): 15 mins, 
CRC screening overview, comparison of test options and selection of a colored brochure to 
correspond to readiness. Spanish translation using original PtDA appraisal (Miller et al 2011), 
literature review, assessment of demographic trends, solicitation of information from target 
population. Trained navigators provided tailored support immediately after clinician encounter.  
Attention control: food safety 
video before encounter and 
usual care after encounter 
Diefenbach 
et al 2018^ 
✓  ✓    ✓ 
Healing Choices: multimedia software on CD-ROM including information about PCa treatment, 
ethnically diverse patient videos, physician’s view of treatment and recovery, opportunity to 
determine values/preferences. Theoretical frameworks and literature review guided content 
selection. Development included conceptual, literacy and cultural appropriateness review, user and 
usability testing, 7th grade reading level, guided by literacy and patient education experts. 
Usual care: spoke to specialist 
who answered questions, 
received standard CIS and NCI 
print materials 
Hoffman et al 
2017 
 ✓ ✓     
Video: 30mins, colorectal cancer screening educational and decision support, encouraging patients 
to talk to their PCP, ask questions and share concerns and preferences using AA family story. 
Content review by experts, prototyping, video production, pilot testing using cognitive interviews. 
Incorporated IPDAS, Ottawa Decision Support Framework, and Integrated Model of Behavior. 
EDAM used to improve saliency for AAs and ensure PtDA was accessible across literacy levels.   
Attention control: hypertension 
video providing similar 
educational content but lacking 
decisional support and tailored 
components 
Ibrahim et al 
2017 
  ✓     
Video: 40mins, discusses knee osteoarthritis treatment options (lifestyle changes, medications, 
injections, complementary therapy and surgery, risks, benefits and known efficacy of each option, 
clinical indications, rehabilitative care, recovery time, effort and cost). Developed by Foundation for 
Informed Medical Decision Making. Same PtDA tested by Vina 2016. 
Educational booklet developed 
by the National Institute of 





et al 2011^ 
 ✓ ✓  ✓ ✓ 
 Interactive computerized web soap opera episodes walk women through BCa  journey, episodes 
adapted to linguistically, race/ethnically and age targeted to user. EDAM utilized. Special design 
considerations for low literate computer users: voice-over navigational instructions, limited on-
screen text. Developed with expert panel, usability interviews with target population, user testing in 
subgroups. Adapted episodes to Spanish. Updated version followed IPDAS guidelines. 
BCa treatment educational 
materials generally provided to 
patients in these hospitals 
Jimenez et al 
2017 
 ✓ ✓ ✓    
Video (3mins) + text message explaining child development and Early Intervention (EI). Focus 
groups and interviews with parents & primary care professionals. Followed IPDAS criteria and 
accommodated low health literacy users using strategies such as plain language, visual 
reinforcement of key ideas, summaries of key information, and provided specific action steps. 
Feedback from parents, leaders from EI agency and other experts in child development. SMS 
reminder based on parent interviews to augment DA intervention. 
Standard care: additional age-
appropriate handout, publicly 
available from the CDC "Learn 
the Signs. Act Early" campaign 
Kuppermann 
et al 2009* 
  ✓ ✓  ✓ ✓ 
Interactive computerized web-program emphasizing decision is personal and depends on values, 
explains screening vs. diagnostic tests, risks/benefits, describes Down Syndrome, gives tailored 
estimates. Focus groups and pilot testing among women and genetic counsellors. Spanish 
translation using forward and backward translation process with three bilingual team members. 
Kuppermann 2014 evaluated same PtDA. 
Computerized version of booklet 
provided to pregnant women by 
California Expanded AFP 
Screening Program obstetricians 
Kuppermann 
et al 2014 
  ✓ ✓  ✓ ✓ 
‘Prenatal Testing: Exploring Your Options’: interactive computer program (audio, video and text 
elements) narrated by bilingual actress. Educational module (general information + role of values 
and preferences), features of screening and tests. Input from clinicians, decision scientists, 
communication/literacy experts, focus groups of women, pilot testing with women and genetic 
counsellors, Spanish translation process. Participants told study would pay for any tests discussed 
for which they did not have insurance coverage. Kuppermann 2009 evaluated same PtDA. 
No intervention or financial 
support provided 
Lepore et al 
2012^ 
✓  ✓ ✓ ✓   
Information booklet “Prostate Cancer: Your Life – You Decide” and telephone counselling session 
(education about risk, benefits and harms of screening, values clarification and shared decision-
making). Feedback from expert consultants and men in target subgroups, cognitive interviews to 
ensure comprehension. Pilot testing conducted with low income undeserved men. Written at 
reduced readability level. SMOG grade level of 7 and Flesch grade level of 2.7 
Telephone education about fruit 
and vegetable intake guidelines + 
education pamphlet 
Marteau et al 
2010^ 
✓  ✓ ✓    
Letter informing participants they are at risk of developing Type 2 diabetes and inviting them to 
screen. Provides diabetes information: risk factors and complications, screening process, possible 
benefits and harms and their likelihood of occurring. Words, numbers and pie charts used to convey 
risks and benefits. Developed iteratively using think-aloud approaches. Flesch-Kincaid Grade level = 
5.76, reading age 11 or above. Text refined using readability tools. 
Standard letter stating 
participant is at increased risk of 
diabetes 
Miller et al 
2011^ 
  ✓ ✓ ✓   
Interactive web-based program (CHOICE): includes video clips, graphics and animations. Presents 
prevalence information, CRC screening  rationale, description of tests. Content based on previously 
validated video guided by subgroup interviews; navigation designed for ‘low-literacy’ subgroup. 
User testing with participants with wide range of computer experience and education level. 
Computer presented program 
about prescription drug refills 
and safety 
Miller et al 
2018^ 
✓  ✓  ✓  ✓ 
Video (8mins) reviewing fecal testing and colonoscopy (based on CHOICE PtDA). Delivered via 
mobile app on iPad ‘mPATH-CRC.’ Participants can self-order test on app, PCP notified if participant 
self-ordered. Participant received follow-up messages with information about test ordered. Content 
and navigation designed for people with low health and computer literacy (simple interface, audio 
Video: 4.3 mins about diet and 




narration). Team included experts in app development, health literacy and CRC screening. Usability 
study conducted in disadvantaged population. All material written at 6th grade level or lower.  
Myers et al 
2005*^ 
 ✓  ✓ ✓  ✓ 
PCa information booklet, risk factors, symptoms, pros/cons of screening, follow-up tests and 
treatment options. Telephone decision counselling session where major decision factors elicited 
and participant identifies top three factors, entered into pre-programmed calculator and 
preference score shared with participant. Content field-tested by literacy expert in face-to-face 
interviews with sub-group. Feedback resulted in simplification of text. Decision counselling protocol 
pilot tested in primary care practices in target community.  
Information booklet addressing 
PCa, risk factors, symptoms, pros 
and cons of screening, follow-up 
tests and treatment options 
Rising et al 
2017 
 ✓  ✓ ✓   
Patients provided with 100-person risk pictograph to depict personalized risk for acute coronary 
syndrome within 45 days. Provides explicit management options. Each patients’ PtDA color coded 
to correspond to level of risk to reduce cognitive demand. Iterative development process whereby 
research team and designers field tested with clinicians and patients in emergency (25% ≤high 
school). Participatory action research design included revisions based on feedback from patients 
and caregivers and ensured IPDAS criteria was met.  
Usual care: clinicians instructed 
to have discussions regarding 
test results and treatment as per 
usual practice 
Ruffin et al 
2007^ 
  ✓ ✓ ✓  
 Interactive web-based education tool: ‘Colorectal Web’. Used graphics, text, and videos to 
encourage patients to weigh preferences to make an informed choice. Content and usability testing 
guided by focus groups and interviews conducted with participants from geographical areas with 
high rates of advanced CRC and a low incidence of CRC screening.   
Non-interactive CRC website 
sponsored by Cancer Research 
and Prevention Foundation 
Schroy et al 
2011 
  ✓ ✓    
Two intervention groups: 1) received interactive computer program using audio-visual and touch-
screen format including descriptions of CRC screening methods, audio and visual comparisons, 
summary of test features, decision-making module. 2) received program and personal risk 
assessment. Subgroup focus groups of racially/ethnically diverse screened and unscreened men and 
women, assess out-of-pocket cost concerns, cultural sensitivity issues, usability tests. 
9 Ways to Stay Healthy and 
Prevent Disease discussing 
generic lifestyle changes other 
than screening for minimizing 
risk of preventable diseases 
Smith et al 
2010^ 
✓ ✓  ✓ ✓  ✓ 
Information booklet + video presenting tailored risk information about the outcomes of screening for 
CRC with FOBT. Informed by interviews with adults of varying education/literacy level, experts in 
adult literacy and linguists. Plain language, basic design, illustrations and simple techniques to reduce 
cognitive effort (reduce amount of text, lay language, glossary, simplified diagrams, active voice, 
contextual information before factual). Existing PtDA adapted to reduce the Flesch-Kincaid Grade 
level from 10 to 7. Pilot testing using same recruitment strategy.  
Standard consumer information 
booklet Flesch-Kincaid readability 
score grade 9 
Street et al 
1995* 
  ✓     
Interactive multimedia program: Options for Treating Breast Cancer, including understanding the 
problem, treatment options (mastectomy and lumpectomy with radiation), and experiences of other 
women who had undergone either mastectomy or lumpectomy.  
Care of Patients with Early Breast 
Cancer brochure (8 pages).  
Taylor et al 
2006^ 
 ✓ ✓ ✓   ✓ 
Two intervention groups: 1) Booklet: 16-page, information about PCa screening, questions to ask 
doctor, glossary, celebrity spokesperson. 2) Video: 25-mins, depicts middle-aged AA man, discussing 
screening with friends, family, doctor; decision process (attempts to understand, fears, doubts, 
questions). Eight focus groups conducted with AA men and two with clinicians and researchers. 
Participants provided feedback. Research team included urologists, nurse, Public Health educators, 
AA men, and behavioral science staff. 
Wait-list: single pre-intervention 
interview occurred 1 month 
following randomization but 
before receipt of intervention 
Trevena et al 
2008 
✓       
Information booklet (20pages): CRC screening definition, baseline risk information over next 10 
years, mortality reduction from screening, outcomes from biennial FOBT, information about how to 
Consumer version of Aus 
guidelines mailed consisting of 3 
21 
 
collect FOBT. Flesch-Kincaid readability score was grade 10. Incorporated expert and lay beliefs about 
core issues for informed choice about FOBT obtained from previous research, including studies 
conducted by the authors. 
pages of text with information 
about biennial FOBT. FK 
readability grade 9 
Vina et al 
2016^ 
  ✓     
Two components: 1) Video (40mins) - see Ibrahim 2017. 2) Motivational interviewing: ~30mins 
session, face-to-face, motivational interviewing by trained, certified interventionists. Participants 
asked thoughts about total knee arthroplasty, goals/preferences regarding arthritis, and provided 
information and support for discussing with PCP. Same PtDA evaluated by Ibrahim 2017.  
Educational booklet developed 
by NIH National Institute of 
Arthritis and Musculoskeletal and 
Skin diseases.  
Volk et al 
2008* 
 ✓ ✓  ✓   
Interactive DVD/CD-based soap opera episodes: 53-68mins, EDAM design, didactic soap-opera 
episodes integrated with interactive learning modules to complement content, navigational 
instructions provided, ethnicity of main character tailored to viewer, story took character through 
process of PCa screening decision. Content tailored using racial/ethnic concordance and social 
matching, acceptability tests conducted in subgroups. 
Audio-booklet: same content, 
accompanied by narration. 
Lacked interactivity of 
intervention, testimonials and 
values clarification exercise 
Williams et al 
2013 
✓    ✓  ✓ 
Booklet (24 pages): Prostate Cancer Screening: Making an Informed Decision. Includes information 
on leading causes of death among men, accuracy of PSA test, PCS guidelines and diagnostic 
procedures and treatments. Adapted to 8th grade readability by plain language experts, usability 
tests in subgroups. 
Usual care educational materials 
– National Cancer Institute’s 3-
page fact sheet. 
Wolf et al 
1996 
    ✓   
Script about PSA screening read aloud by research assistant: overview of PSA screening, stated 
lifetime probability of developing and dying from PCa, known risk factors, ability of PSA test to detect 
early asymptomatic cancer, description of management options and major complications. Content 
developed by physician experts, piloted with primary care patients via subgroup interviews, assessed 
for comprehensibility. 
Brief statement: blood test 
known as the PSA is available 
that can sometimes detect early 
prostate cancer before it is 
otherwise apparent 
PCP=Primary Care Physician, IPDAS=International Patient Decision Aid Standards, ODSF=Ottawa Decision Support Framework, EDAM=Edutainment Decision Aid Model, AA=African American, 
PCa=prostate cancer, CRC=colorectal cancer, BCa=breast cancer, PSA=prostate-specific antigen, AA=African American, FK= Flesch-Kincaid 
* Included in 2014 Cochrane Review of PtDAs but excluded from 2017 update due to comparing simple versus detailed PtDAs 
^ Development reported in separate paper 
# Decision-making outcomes reported in Brenner et al., 2016, implementation outcomes reported in Reuland et al., 2017 
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Cognitive demand: readability, comprehension and actionability scores of PtDAs 
We were able to access 11 PtDAs out of the total 24 unique PtDAs from journal articles or 
supplementary material (n=2), decision-aid repositories (n=2) or via direct contact with the 
PtDA author (n=7). For two of these, we were only able to access a component of the 
intervention; an information booklet evaluated by Myers et al. (accompanied by motivational 
interviewing),39 and the video component of an iPad program evaluated by Miller et al.19 Of 
those obtained, the readability, understandability and actionability is shown in Table 4. Using 
our measure of readability, none of the PtDAs were written at or below 8th grade reading level. 
Notably, none of the PtDAs were written at 6th grade level or below.  
Using the PEMAT measure, understandability scores were high with 92% (n=11) achieving the 
recommended threshold (Table 4). However, only 42% (n=5) of PtDAs achieved the 
recommended threshold for actionability. The mean understandability score was 83.3% 




Table 4. Readability and Patient Education Materials Assessment Tools (PEMAT) scores for 
PtDAs which could be accessed  
Authors and year Readability score*  
PEMAT score# 
Score >70% = suitable for lower literacy popln 
Understandability (%) Actionability (%) 
Print    
Boulware et al 2018 9.07 94.1 60.0 
Marteau et al 2010 8.98 81.3 66.7 
Myers et al 2005 9.99 87.5 66.7 
Rising et al 2017 12.66 75.0 75.0 
Smith et al 2010ǂ 8.47 93.8 83.3 
Taylor et al 2006 11.49 75.0 50.0 
Trevena et al 2008 11.54 87.5 60.0 
Audio-visual (computerized program or video) 
Boulware et al 2018 12.82 83.3 100.0 
Jibaja Weiss et al 2011+ 10.60 92.3 100.0 
Miller et al 2018 11.49 84.6 50.0 
Reuland et al 2017 11.23 84.6 75.0 
Taylor et al 2006 8.25 60.0 33.3 
*readability scores are the average of the SMOG index and the Gunning Fog index. High scores indicate the PtDA is harder 
to read. 
# print PtDAs assessed using the PEMAT-P (printable materials), video and computerized PtDAs assessed using the PEMAT-
A/V (audiovisual materials)  
ǂ We did not assess the video component of the PtDA evaluated by Smith et al., as we were informed by authors that the 
content was identical  
+PtDA updated after the study to meet IPDAS quality criteria checklist, version used for readability and PEMAT analysis may 
differ from the version evaluated in the study 
^ Wolf et al 1996 excluded from readability and PEMAT analysis due to format of PtDA 
 
Impact of the PtDAs  
In total, 19 of the 20 reviewed studies that included at least 50% of participants from a 
disadvantaged population assessed the overall effectiveness of their PtDA on decision making 
and health outcomes. The remaining study did not report overall effectiveness of the PtDA as it 
focused on effectiveness of PtDA across subgroups.27 Fourteen studies conducted separate 
analyses exploring either the moderating effect of disadvantage on the effectiveness of PtDAs, 
or the impact on disadvantaged groups only (either instead of, or in addition to, the overall 
analysis) (Table 6). One study met our inclusion criteria for conducting a separate analysis as 
they conducted a bivariate analysis across disadvantaged groups, however, the interaction 
between disadvantage and intervention was not analyzed.36 
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Impact on attributes of the choice 
A common reported measure of effectiveness of PtDAs relating to attributes of the choice was 
knowledge (n=12). Of these 12 studies, 10 reported knowledge as a continuous outcome and 
were included in the meta-analysis (Figure 3). After standardizing means to a scale of 1 to 100, 
the pooled mean difference was 14.65 (95% CI 9.48, 19.83) with substantial heterogeneity 
(I2=96%, p<0.001). Two studies could not be pooled into a meta-analysis (Table 5): one reported 
knowledge dichotomously (knowledge increased in the PtDA group),30 and one was a pilot 
study that reported 14 items relating to knowledge/attitudes without merging into one score.24 
 
Figure 3. Forest plot for knowledge 
Seven studies analyzed moderating effects of disadvantage on knowledge (Table 6). Knowledge 
increases resulting from a PtDA were evident in most studies across both disadvantaged and 
non-disadvantaged groups. However, one study found moderating effects of race, such that 
knowledge increases were significantly greater for white participants who received their PtDA 
compared to non-white participants.32  
Two studies assessed accurate risk perception so were not pooled in a meta-analysis (Table 5). 
PtDAs increased accuracy of risk perception for prenatal genetic testing compared to 
control,16,17 but this difference was not maintained at follow up.16  
Two studies assessed values-choice congruence so were not pooled in a meta-analysis (Table 5). 
They found participants who received the PtDA made more informed choices (adequate 
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knowledge and attitudes-behavior congruence),22 and integrated decisions (clear values and 
adequate knowledge)30 than those who did not receive the PtDA. 
Impact on attributes of the decision-making process  
Nine studies assessed decisional conflict. Six were included in the meta-analysis (Figure 4). On a 
scale of 1 to 100, the pooled mean difference was -4.16 (95% CI -7.38, -0.93) with substantial 
heterogeneity (I2=81%, p<001). We conducted a subgroup analysis according to scale (original 
decisional conflict scale versus low-literacy version) and found that the pooled mean difference 
for studies using the original scale was -1.58 (95% CI -2.66, -0.49) with no heterogeneity (I2=0%, 
p=0.48) (Figure 5). The pooled mean difference for studies using the low literacy scale was -8.93 
(95% CI -17.14, -0.73) with substantial heterogeneity (I2=86%, p<001) (Figure 6).  
Of the remaining three studies that were not included in the meta-analysis (Table 3), one 
reported decisional conflict dichotomously and found that the PtDA reduced decisional conflict 
compared to control.36 One only reported the values clarity subscale and found no differences 
between PtDA and control groups.30 One did not provide sufficient detail for inclusion.31  
Figure 4. Forest plot for decisional conflict. 
Figure 5. Subgroup forest plot for decisional conflict (studies using the original Decisional 




Figure 6. Subgroup forest plot for decisional conflict (studies using the low-literacy version of 
the Decisional Conflict Scale only). 
Other outcomes relating to decision-making were reported but not pooled in a meta-analysis 
(Table 5). For satisfaction with decision, this was because four studies used different 
scales/items or provided insufficient information, but all reported no differences between PtDA 
and control groups.22,26,31,36 Only two studies measured satisfaction with the decision-making 
process, so were not included in a meta-analysis: one reported a difference between groups29 
and the other did not.26 Three studies assessed participation in decision,16,22,33 but only one 
reported a statistically significant increase in the PtDA group.33 
Four studies measured patient-clinician communication.18,19,37,38 Three were pooled in a meta-
analyses (Figure 7). The relative risk was 1.62 (95% CI 1.42, 1.84) with no heterogeneity (I2=0%, 
p=0.78). The remaining study was not included in the meta-analysis because it combined 
reporting of discussions with doctor and/or family (Table 5). No differences between PtDA and 
control groups were evident. 
Figure 7. Forest plot for patient-clinician communication. 
Five studies analyzed moderating effects of disadvantage on attributes of the decision-making 
process (Table 6). Three analyzed decisional conflict: two found no moderating effects,31,32 but 
one reported that the PtDA was more effective in reducing decisional conflict in low literacy 
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participants than high literacy participants.27 One study also found increased decisional support 
(DCS subscale) after receiving the PtDA was more pronounced for African American and lower 
educated participants.25 Regarding participation in decision, two studies found that there were 
no differences across subgroups,28,32 but another found their PtDA increased low literacy 
participants’ willingness to be involved compared to control more than for high literacy 
participants.27 One study found no moderating effects of race on decisional satisfaction.31  
Two studies analyzed moderating effects of disadvantage on patient-clinician communication 
and both found no moderating effects of race or education.18,28  
One study analyzed moderating effects of disadvantage on trust in physician and found greater 
increases among those with lower health literacy receiving the PtDA than those with higher 
health literacy.32  
Impact on attitudes 
Four studies assessed attitudes towards a procedure or test. These were not pooled in a meta-
analysis because of the varied attitudes that were measured. Details are shown in Table 5. Of 
these four studies, only one reported a significant difference: attitudes towards bowel cancer 
screening were slightly more negative for those who received the PtDA compared to control.22 
Impact on behavior (preferences, intentions, behavioral outcomes, adherence to chosen 
option) 
Preferences for different screening tests were measured in six studies. Four reported the 
proportion undecided so were included in the meta-analysis.18-20,26 The pooled relative risk was 
0.23 (95% CI 0.11, 0.50) with high heterogeneity (I2=66%, p=0.03) (Figure 8). Two were not 
included in the meta-analysis because they reported preference as increased willingness for the 
procedure or provided insufficient information: both reported no differences between groups 
(Table 5).29,40 Additionally, one study found their PtDA was more likely to affect participants’ 
pre-natal testing plans compared to control, but this difference was not maintained at follow-
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up (Table 5).16  
 
Figure 8. Forest plot for proportion undecided. 
Intentions, readiness and interest were measured in eight studies. Five reported cancer 
screening intentions using proportions and were included in the meta-analysis (Figure 
9).18,19,30,33,38 The pooled relative risk was 1.06 (95% CI 0.96, 1.16) with moderate heterogeneity 
(I2=65%, p=0.02). Three studies were not included in the meta-analysis due to continuous 
measurement or assessing slightly different constructs (i.e. readiness/interest). All three found 
the PtDA increased screening intention, interest or readiness (Table 5).20,29,35 
 
Figure 9. Forest plot for screening intention 
Two studies analyzed moderating effects of disadvantage on ability to state a screening 
preference and screening readiness. Improvements in these outcomes as a result of receiving 
the PtDA relative to control were evident in both low and high health literacy groups,20 as well 
as both Latino and non-Latino participants.18 
Behavioral outcomes were measured in 15 studies. Of these 15 studies, five assessed test 
ordering in the cancer context and were included in the meta-analysis (Figure 10).18-20,29,33 The 
pooled relative risk was 1.40 (95% CI 0.98, 2.01) with substantial heterogeneity (I2=90%, 
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p<0.001). Nine assessed test completion for cancer screening and were pooled in the meta-
analysis (Figure 11). The pooled relative risk was 1.35 (95% CI 0.93, 1.94) with substantial 
heterogeneity (I2=91%, p<0.001). Five studies reported behavioral outcomes that were not 
pooled due to their heterogeneity (Table 5). Three found no behavioral differences between 
PtDA and control groups.24,37,40 However, some behavior change was evident in two studies: 
one reported increased receipt of total knee replacement surgery as a result of viewing the 
PtDA34 and another found decreased use of invasive prenatal diagnostic testing after receiving a 
PtDA.17 One study did not report enough details but reported no statistically significant 
differences in behavior.31 
Figure 10. Forest plot for screening test ordered.  
 
Figure 11. Forest plot for screening test completed. 
Eight studies analyzed moderating effects of disadvantage on behavioral outcomes. Five 
reported no moderating effects of poverty,21 health literacy,19,20 income19 or race.19,23,31 One 
found their PtDA increased intake and evaluation for early intervention for developmental 
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delay compared to control within a low health literacy group, but did not report statistical 
tests.24 Brenner et al. found no moderating effects of ethnicity on colorectal cancer screening 
test ordering,18 but their follow-up paper reporting implementation outcomes showed greater 
screening completion among Latinos and those without private insurance.42 
Two studies assessed adherence to a chosen option and were not included in a meta-
analysis.29,38 One measured intention-behavior congruence for prostate cancer screening and 
found no differences between PtDA and control groups at 1 or 2 year follow up.38 The other 
study did not report enough detail.29  
Impact on health outcomes 
Anxiety was measured in three studies with no differences between groups reported (Table 
5).22,30,38 These were not pooled in a meta-analysis because they used quite different scales. 
Two studies also measured decisional regret16,17 and one measured confidence in decision-
making;22 both reporting no differences between groups (Table 5).  
Attitudes towards and acceptability of PtDAs  
Attitudes and acceptability of the PtDAs were measured in different ways and studies report 
varied results. These are described in more detail in the Appendix. 
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Table 5. Outcomes of trials including >50% disadvantaged population  
Authors and year Scale used Timing 








Attributes of the choice – Knowledge 
Jimenez et al 2017 14-item scale developed in consultation with 
pediatric experts, informed by qualitative 
interviews with parents and providers 
Post-intervention      See footnote# 
Trevena et al 2008 4 free-text questions; mark given for correct 
piece of information (max score=3), mark 
deducted for piece of incorrect information, % 
adequate knowledge 
Post-intervention 134 20.9% 137 5.8% 0.0001 Adequate knowledge if positive score for 
understanding potential benefits and 
harms of screening  
Attributes of the choice – Accurate risk perception 
Kuppermann et al 
2009 
Procedure-related miscarriage estimate  
% correctly estimated risk 
Post-intervention 244 64.9% 252 48.1 0.002  
1-2 weeks later 212 55.7% 223 51.0% 0.39 
Down Syndrome affected fetus estimate Post-intervention 244 63.5% 252 15.1% <0.001  
1-2 weeks later 212 42.8% 223 15.7% <0.001 
Kuppermann et al 
2014 
Miscarriage risk Post-intervention 357 73.8% 353 59.0% <0.001  
Down Syndrome risks Post-intervention 357 58.7% 353 46.1% 0.001 
Lepore et al 2012 Benefits:risks % agree benefits outweigh risks Post-test 215 33.5% 216 28.2% >0.05 Measured perceived importance, not 
accuracy 
Attributes of the choice – Values-choice congruence 
Smith et al 2010 Informed choice if adequate knowledge + 
attitudes congruent with behavior 
Post-intervention 357 34% 172 12% < 0.001  
Partly uninformed choice – completing test with 
positive attitudes but inadequate knowledge 
Post-intervention 357 15% 172 41% NA  
Trevena et al 2008 Integrated decision  Post-intervention 134 10.4% 137 1.5% 0.002 Values clear + adequate knowledge 
Attributes of the decision-making process – Decisional conflict 
Taylor et al 2006^ DCS low-literacy version, 10-item; 2 excluded, 
dichotomized; Waitlist randomized to print/video 
arms before 1-month assessment. 
Baseline 84 33.3 74 41.9 > 0.05 Print DA (column), video DA (n=80): 31.3 
1-month 84 8.3 - - <0.05 Print DA (column), video DA (n=80): 24.1 
Trevena et al 2008 DCS: values (% <25 on values subscale of DCS) Post-intervention 134 61.9% 137 59.1% 0.63 Values clarity only reported 
Williams et al 2013 10-item low-literacy version. (See paper for more 
details regarding intention-to-treat and per-
protocol analysis and delivery modes). 
Baseline NA NA NA NA NA No significant main effects for booklet 
type 2-months 185 NA 175 NA NA 
13-months NA NA NA NA NA 
Attributes of the decision-making process – Satisfaction with decision 
Jibaja-Weiss et al 
2011 
SWD scale (6-item, range 1-5) Pre-surgery 40 2.87 36 2.85 0.65  
Smith et al 2010 Decision attitude scale (10-item) Post-intervention 357 NA 173 NA 0.49  
Taylor et al 2006 Single item 4-point scale; dichotomized (% high) Baseline 84 76% 74 78% >0.05 Print DA (column), video DA n=80): 78% 
1-month 84 85% - - >0.05 Print DA (column), video DA (n=80): 80% 
Williams et al 2013 SWD scale 6-item measure; range1-5 
Reported as % highly satisfied (scored 4 or 5) 
2-months 226 NA 223 NA NA Multivariate analyses revealed no 
significant main effects or interactions 13-months 226 NA 223 NA NA 
Attributes of the decision-making process – Satisfaction with decision-making process 
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Jibaja-Weiss et al 
2011 
Modified SWDMP scale (7-item; range 1-3)  Pre-surgery 44 1.12 39 1.15 0.70  
Schroy et al 2011^ SWDMP scale (12-item; range 12-60) Post-test 205   50.7 217 46.7 <0.001 PtDA+risk calculator YDR (n=214): 50.5 
6 months 22 27% 26 19% > 0.05 PREPARED PLUS (n=26): 19% 
Attributes of the decision-making process - Participation in decision 
Hoffman et al 
2017 
Patient self-advocacy scale - 12 items; range 1-3 Post-intervention 59 1.6 28 1.8 0.01 3-point scale, low=more self-advocacy 
Kuppermann et al 
2009 
Information given by provider 26-30 wks gestation 202 44.8% 218 49.2% 0.40 Satisfaction with decision-making 
involvement - 3 items  
% responding ‘very satisfied’ or ‘satisfied’ 
The way your provider involved you 26-30 wks gestation 202 44.3% 218 48.1% 0.45 
The degree of involvement you and provider had 26-30 wks gestation 202 72.6% 218 79.9% 0.10 
Smith et al 2010 Involvement preference (making decision on 
own) 
Pre-intervention 384 37% 188 41% NA Difference across timepoints for both 
groups < 0.001.  Post-intervention 355 90% 171 96% NA 
Patient-clinician communication 
Boulware et al 
2018^ 
Discussion about LDKT with doctor or family Baseline 30 17% 31 13% > 0.05 PREPARED PLUS (n=31): 36% 
6 months 22 23% 26 23% > 0.05 PREPARED PLUS (n=26): 23% 
Discussion about LDKT with doctor and family Baseline 30 27% 31 33% > 0.05 PREPARED PLUS (n=31): 10% 
6 months 22 27% 26 19% > 0.05 PREPARED PLUS (n=26): 19% 
Attitudes 
Boulware et al 
2018 
Beliefs about kidney transplant – 4 items Four timepoints 30 Graphs 31 Graphs NA PREPARED PLUS (n=31) Did not change 
among study groups – see text on page 31  Concerns about LDKT – 10 items Four timepoints 30 Graphs 31 Graphs NA 
Hoffman et al 
2017 
Attitudes toward CRC screening: 3 items; 1-5 
scoring, max score 15 
Baseline 58 9.7 28 8.9 - *Change scores not significant 
High = positive attitudes Post-intervention 58 9.4 28 8.6 0.49* 
Perceived social normative pressures about CRC 
screening: 3 items; 1-5 scoring, max score 15;  
Baseline 58 10.5 28 11.6 - *Change scores not significant 
Higher = positive perceived social norms Post-intervention 58 9.4 28 8.6 0.49* 
Jimenez et al 2017 Knowledge and attitudes (14 items)       See footnote# 
Smith et al 2010 6 item scale, range 6-30, higher = positive Post-intervention 357 26.4 173 27.3 0.003  
Behavior – Intentions and preferences 
Kuppermann et al 
2009 
Intervention affected prenatal testing plans 
 
1-2 weeks 212 47.8% 223 27.5% < 0.001 % of women responding ‘strongly agree’ 
or ‘agree’ 26-30 wks gestation 202 38.2% 218 36.0% 0.85 
Miller et al 2011 Screening readiness Immediately after 132 52% 132 20% 0.001  
Schroy et al 2011^ Preferences (captured in module) Post-intervention 212 NA 223 NA >0.05  
Screening intentions (5-point); scheduling appt. Post-intervention 212 3.9 231 3.9 < 0.001 PtDA + risk calculator YDR (n=223): 4.3 
Screening intentions (5-point); completing test Post-intervention 212 4.3 231 3.9 < 0.001 PtDA + risk calculator YDR (n=223): 4.3 
Vina et al 2016 TKA preference (% increased willingness) 2-weeks 238 34% 252 33% 0.779  
3 months 238 33% 252 26% 0.106 
12 months 238 29% 252 27% 0.678 
Wolf et al 1996 Interest in PSA screening – 5-point response  Post-intervention 103 3.8 102 3.0 <0.001  
Behavior – Behavioral outcomes 





difference in LDKT 
Initiation of recipient medical evaluation for live 
donor kidney transplant – no donor identified 
Baseline 30 0% 31 3% NA PREPARED PLUS (n=31): 7% 
6 months 22 0% 26 4% NA PREPARED PLUS (n=26): 8% 
Completion of recipient medical evaluation for 
live donor kidney transplant – no donor identified 
Baseline 30 3% 31 0% NA PREPARED PLUS (n=31): 7% 
6 months 22 0% 26 4% NA PREPARED PLUS (n=26): 0% 
Initiation of recipient medical evaluation for live 
donor kidney transplant – donor identified 
Baseline 30 13% 31 19% NA PREPARED PLUS (n=31): 13% 







Completion of recipient medical evaluation for 
live donor kidney transplant – donor identified 
Baseline 30 10% 31 7% NA PREPARED PLUS (n=31): 3% 
6 months 22 18% 26 15% NA PREPARED PLUS (n=26): 15% 
Ibrahim et al 2017 Received recommendation for surgery  6-months 168 20.2 168 15.5 0.25 Intention-to-treat analysis. Per-protocol: 
PtDA n=150 and control n=154 Receipt of surgery  12-months  168 14.9% 168 7.7% 0.04 
Jimenez et al 2017 Completed intake for early intervention 6-months 31 65% 33 64% 0.80  
Completed evaluation for early intervention 6-months 31 55% 33 52% 0.68  
Kuppermann et al 
2014 
Invasive diagnostic test use: amniocentesis Post-intervention 357 3.9% 353 8.2% 0.02  
Invasive diag. test use: chorionic villus sampling Post-intervention 357 2.4% 353 4.1% 0.22 
Invasive diag. test use: any Post-intervention 357 5.9% 353 12.3% 0.005 
Testing strategy: none Post-intervention 357 25.6% 353 20.4% 0.005  
Testing strategy: screening test only Post-intervention 357 68.5% 353 67.3% 0.02 
Testing strategy: invasive without screening Post-intervention 357 3.0% 353 4.6% 0.37 
Testing strategy: screening followed by invasive Post-intervention 357 2.9% 353 7.7% Ref 
Vina et al 2016 Receipt of referral to orthopedic surgery 12-months 238 32% 252 36% 0.277  
Williams et al 2013 Screening behavior outcomes 
No intervention effect (p > 0.30) 
2 months 185 NA 175 NA NA Overall increase in % screened from 2-
months to 13-months (all p < 0.001) 13 months NA NA NA NA NA 
Behavior – Adherence to chosen option 
Lepore et al 2012 Congruence between intention and actual 
behavior 
1-year follow up 244 55.3% 246 58.1% > 0.05 Medical claims scanned so full sample size 
accessed 2-year follow up 244 59.0% 246 59.3% > 0.05 
Schroy et al 2011 Test concordance - % who ordered preferred test  Post-test 212 NA 223 NA NA Control is YDR intervention group 
Health outcomes – Anxiety 
Lepore et al 2012 7-item subscale of Hospital Anxiety and 
Depression Scale (range 0-21); higher = more 
anxiety 
Pre-test 244 2.05 246 1.95 > 0.05  
Post-test 215 2.02 216 2.16 > 0.05  
Smith et al 2010^ State Trait Anxiety Inventory (6-item; range 20-
80) 
Post-intervention 357 28.2 173 28.4 0.80 Short form; higher = more anxiety 
Worry about developing bowel cancer: (4-item; 
dichotomized: ‘none’ or ‘a bit’ vs ‘quite’ or ‘very’)  
Baseline 196 91.0~ 188 92% >0.05 DA+questions; DA+ DVD (n=188): 94.0 
Post-intervention  357 94.0 173 92.0 0.78 % responding ‘none’ or ‘a bit’ 
Trevena et al 2008 State Trait Anxiety Inventory (6-item; range 20-
80)  
Post-intervention 134 9.33 137 9.58 0.59 Short form; higher = more anxiety 
Health outcomes – Regret 
Kuppermann et al 
2009 
3 questions, % responded definitely-mostly true 26-30 wks gestation 202 9.6% 218 12.8% 0.28 5-point scale; dichotomize 
Kuppermann et al 
2014 
Decision Regret Scale (5-item) Post-intervention 357 8.29 353 6.83 0.12  
Health outcomes – Confidence 
Smith et al 2010 Decision self-efficacy scale (3-item; adapted)  Post-intervention 357 4.7 173 4.6 0.91   
Table only includes studies which included >50% disadvantaged group. NA=data not available in published studies; requested data from authors. P-values refer to between-group differences 
at each time point unless otherwise specified. 
^Study had a second intervention group; results reported in ‘notes’ column. 
#Knowledge/attitudes measured with 14 items (6-point scale). PtDA: greater understanding of child developmental delay, p=0.02; more positive attitudes towards early intervention, p=0.03 
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Table 6. Outcomes of the subgroup analyses to test moderating effects of disadvantage    
Authors 
and year 
Overall finding and subgroup analysis details Results 
Attributes of the choice – Knowledge 
Brenner et al 
2016 
PtDA increased knowledge relative to control. Restricted analysis 
to Latino participants only and assessed the interaction between 
intervention group and site (North Carolina vs. New Mexico)# 
Similar effects when analysis restricted to Latino participants only 
Intervention: baseline 2.7, follow-up 4.5 
Control: baseline 2.5, follow-up 2.8, adjusted difference 1.6 (1.2, 1.9), (p<0.001) 
North Carolina: 2.3 increase vs. New Mexico: 1.5 increase* (p<0.001) 
Hoffman et 
al 2017 
PtDA increased knowledge relative to control. Assessed the 
interaction between intervention group and health literacy 
No interaction effect  
Rising et al 
2017 
PtDA increased knowledge compared to control. Numbers within 
PtDA group only reported. 
Examined the moderating effect of different types of 
disadvantage within the PtDA group only. 
 
 
Race – white: 11.0% knowledge increase vs. non-white: 4.8% increase, (p=0.018).  
No difference in knowledge of risk (p=0.177) 
Income - No difference in knowledge (p=0.317) or knowledge of risk (p=0.519) 
Insurance - No difference in knowledge (p=0.236) or knowledge of risk (p=0.834) 
Education - No difference in knowledge (p=0.059) or knowledge of risk (p=0.2) 
Health literacy - No difference in knowledge (p=0.095) or knowledge of risk (p=0.626) 
Numeracy - PtDA: typical group 10.6% increase vs. low group 4.7% increase (p=0.025). No significant 
difference in knowledge of risk (p=0.282) 
Trevena et al 
2008 
PtDA increased knowledge relative to control.  
Assessed the interaction between intervention group and 
education (categorized as left school <16 years/high school >16 
years/tertiary) 
PtDA vs. control:  
Left school<16 years: 50% vs. 17.8% 
High school>16 years: 31.3% vs. 19.4% 
Tertiary education: 79.4% vs. 32.1%   
Volk et al 
2008 
Compared the effect of intervention across low and high-literacy 
sites 
Low-literacy subjects had lower scores than high-literacy, but both groups had significant 
improvements regardless of PtDA they received. Means not available. 
Williams et 
al 2013 
No significant differences between PtDA and control groups. 
Assessed the interaction between intervention and race 
(dichotomized African American/whites) 
No differences in effect of PtDA between African American (n=330) and whites (n=162) 
Attributes of the decision-making process 
Diefenbach 
et al 2018 
PtDA increased decisional support relative to control. Assessed 
the interactions between intervention and race (African 
American/White), and intervention and education 
(lower/higher) 
Race - greater increase in decisional support after receiving PtDA for African Americans, B=-0.18, b=-
9.65 (p=0.04) 
Education - greater increase in decisional support after receiving PtDA for lower educated 
participants, B=0.21, b-3.87 (p=0.05) 
Rising et al 
2017 
PtDA decreased decisional conflict and increased patient 
involvement relative to control. Examined the moderating effect 
of different types of disadvantage within the PtDA group only. 
 
Race - No difference in decisional conflict (p=0.863) or involvement in decision (p=0.316) 
Income - No difference in decisional conflict (p=0.366) or involvement in decision (p=0.832) 
Insurance - No difference in decisional conflict (p=0.167) or involvement in decision (p=0.727) 
Education - No difference in decisional conflict (p=0.962) or involvement in decision (p=0.552) 
Health literacy - No difference in decisional conflict (p=0.829) or involvement in decision (p=0.812) 
Numeracy - No difference in decisional conflict (p=0.454) or involvement in decision (p=0.885) 
Street et al 
1995 
No significant differences between PtDA and control groups. 
Assessed the interactions between intervention and 
age/education+ as well as overall comparison between younger, 
more educated participants and older, less educated participants.  
No interaction between intervention and age/education for patients’ perception of involvement 
 
No interaction between intervention and age/education for patients’ perceived control over decision 
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Volk et al 
2008 
No overall effects of PtDA and control groups reported. 
Compared the effects of intervention across low and high-
literacy sites 
Low-literacy - Decisional conflict (PtDA vs. control): 12.0 v. 21.7 (p=0.04). Values 17.4 v. 34.9 
(p=0.03), uncertainty 5.8 v. 6.8 (p=0.8), informed 9.1 v. 18.8 (p=0.9), social support 17.8 v. 27.6 
(p=0.12).  
High-literacy - no differences 
Low-literacy - a) illness & treatment education: PtDA 1.45 v. control 1.69 (p=0.03), b) assertiveness: 
no difference, c) mindful nonadherence: no difference 
High-literacy - no differences in patient involvement in decision-making. 
Williams et 
al 2013 
No significant differences between PtDA and control groups. 
Assessed the interaction between intervention and race 
(dichotomized African American/whites) 
No differences between African American (n=330) and whites (n=162) in decisional conflict or 
satisfaction with decision 
Patient-clinician communication 
Brenner et al 
2016 
PtDA increased discussion relative to control. Restricted analysis 
to Latino participants, assessed interaction between PtDA group 
& site (Nth Carolina vs. New Mexico)# 
Similar screening discussion effects when analysis restricted to Latino participants only (no test 
statistic) 
North Carolina 41.6% screening discussion increase vs. New Mexico 17.3% p=0.015 
Street et al 
1995 
Assessed the interactions between intervention and 
age/education+. as well as overall comparison between younger, 
more educated participants and older, less educated participants. 
No interaction for asking questions.  
No interaction for offering opinions.  
No interaction for producing expressions of concern.  
No interaction for active communication.  
No interaction for use of patient-centered responses.  
Trust in physician 
Rising et al 
2017 
No significant differences between PtDA and control groups. 
Examined the moderating effect of different types of 
disadvantage within the PtDA group only. 
 
Race - no difference (p=0.062) 
Income - no difference (p=0.371) 
Insurance - no difference (p=0.991) 
Education - no difference (p=0.348) 
Health literacy - low: PtDA = 3.7 trust increase, typical: DA = 1.4 decrease (p=0.011) 
Numeracy - no difference in trust in physician (p=0.090) 
Behavior - Intentions and preferences 
Brenner et al 
2016 
PtDA increased screening intent relative to control. 
Restricted analysis to Latino participants only and assessed the 
interaction between intervention group and site (North Carolina 
vs. New Mexico)# 
Similar screening intent effects when analysis restricted to Latino participants 
PtDA: baseline 71%, follow-up 94%; control: baseline 70%, follow-up 85%, adjusted difference 9.3%; 
p<0.05 
Similar screening intent effects, North Carolina vs. New Mexico (p=0.642) 
Miller et al 
2011 
PtDA increased ability to form test preference and intent to 
receive screening relative to control. 
Assessed the interaction between intervention group and health 
literacy (REALM tool) 
Limited: PtDA 76% stated screening preference vs. control 51% (p<0.001) 
Adequate: PtDA 93% states screening preference vs. control 60% (p<0.001) 
Limited: PtDA 60% ready to receive screening vs. control 24% (p<0.001) 
Adequate: PtDA 42% ready to receive screening vs. control 15% (p<0.05) 
Behavior – Actual behavior 
Brenner et al 
2016* 
PtDA increased test ordering and screening completion relative to 
control. 
Restricted analysis to Latino participants only and assessed the 
interaction between intervention group and disadvantaged 
groups. 
Similar test ordering effects when analysis restricted to Latino participants 
PtDA 93% vs. control 71%, adjusted difference 23.4% (p<0.001) 
Observed larger effect of screening completion among Latinos (49%) vs. non-Latinos (black 25%, 
white 40%), (p=0.17, not significant) 
Observed larger effect of screening completion by insurance status; none=34%, public 54%, private 
12% (p=0.29, not significant) 
Similar effects across North Carolina & New Mexico# on test ordering (p=0.185). Observed larger 




Education - No difference in screening completion (p=0.74) 
Literacy - No difference in screening completion (p=0.82) 
Language - No difference in screening completion (p=0.29) 
Income - No difference in screening completion (p=0.13) 
Employment - No difference in screening completion (p=0.72) 
Jimenez et al 
2017 
No significant differences between PtDA and control groups.  
Compared effect of intervention across low and high-health 
literacy groups  
Completed intervention intake for low health literacy group: PtDA 67% vs. control 40% 
Completed intervention evaluation for low health literacy group: PtDA 58% vs. control 30%  
Marteau et 
al 2010 
No significant differences in screening attendance between PtDA 
and control groups. Assessed the interaction between 
intervention group and social deprivationǂ 
No interaction. However, attendance decreased with deprivation (p<0.01)  
Lowest deprivation tertile: 64.3% attended  
Highest deprivation tertile: 47.5% attended 
Miller et al 
2011 
PtDA increased test ordering and test completion relative to 
control. Assessed the interaction between intervention group and 
health literacy (REALM tool). 
Limited: PtDA 34% ordered screening test vs. control 26% (p>0.05) 
Adequate: PtDA 25% ordered screening test vs. control 16% (p>0.05) 
Limited: PtDA 21% completed screening vs. control 16% (p>0.05) 
Adequate: PtDA 17% completed screening vs. control 10% (p>0.05) 
Miller et al 
2018 
PtDA increased test ordering relative to control. 
Assessed the interaction between intervention group and 
income, health literacy and race (no statistically significant 
interaction between intervention and subgroups). 
>20k: PtDA 38% vs. control 15%; <20k: PtDA 25% vs. control 15%  
Adequate: PtDA 34% vs. control 15%; Limited: PtDA 24% vs. control 16%  
Non-Hispanic white: PtDA 34% vs. control 19% 
Not non-Hispanic white: PtDA 27% vs. control 12% 
Rising et al 
2017 
Overall effect of PtDA on cardiac stress testing not reported. 
Examined the moderating effect of different types of 
disadvantage within the PtDA group only. 
 
Race - White patients had lower odds of having cardiac stress test; 0.48 (p=0.004) 
Income - Income > $40k group had lower odds of having cardiac stress test; 0.54 (p=0.028) 
Insurance - No difference in testing rates (p=0.249) 
Education - No difference in testing rates (p=0.613) 
Health literacy - No difference in testing rates (p=0.054) 
Numeracy - No difference in testing rates (p=0.927) 
Ruffin et al 
2007 
PtDA increased screening rates relative to control. 
Assessed interaction between intervention group and race 
No difference in impact of intervention on CRC screening rates, OR=1.1, 95% CI: 0.90-1.10 
Williams et 
al 2013 
No significant difference between PtDA and control groups. 
Assessed interaction between intervention group and race 
No differences between African American (n=330) and whites (n=162) in prostate cancer screening 
*Implementation outcomes reported in separate paper (screening completion; Reuland et al, 2017) 
# North Carolina represents new and rapid Latino immigration, whereas New Mexico represents regions with established, multi-generational Latino populations. 
ǂ Measured using index of multiple deprivation 




As part of the IPDAS 2.0 process, we sought to update a review of health literacy and PtDAs 
published in 2013.2  Specifically we examined the extent to which PtDAs are designed to meet 
the needs of low health literacy and disadvantaged populations and their impact on decision-
making and health outcomes. The included studies comprised almost 10,000 
patients/community members and indicated that of the 213 PtDAs developed and included as 
part of the Cochrane review and updates since 2006, only 11% of PtDAs (n=24) were developed 
for, or evaluated with patients and populations who are disadvantaged with respect to health 
literacy, education, income, race/ethnicity, neighborhood or health insurance. This represents 
an increase from 5% reported in 2013 (although note that slightly different criteria were used 
for this search),2 yet is still remarkably low given the number of patients in the health system 
who are disadvantaged and likely to require health decision support. Of the PtDAs that were 
developed and evaluated only one third (n=8) adhered to the IPDAS instrument and IPDAS 
minimum standards by reporting any readability statistic. Only 7 PtDAs reported that they met 
the Grade 8 reading level criteria (the reading level recommended for an average population 
sample), a requirement of the original IPDAS quality criteria checklist. However, among the 
subset that were available to be assessed independently, none when independently reviewed 
met the criteria. This is partly due to the methods we used in our independent review process 
for preparing and analyzing the PtDA text. In particular, the readability calculator we used is 
considered superior to other readability calculators (as recommended by health literacy 
experts) but has not been widely used by PtDA developers. In our assessment of 
understandability and actionability using the PEMAT which requires the rater to make a more 
subjective assessment of materials and coded by multiple coders, we found that the PtDAs 
scored well on the understandability domain but poorly on the actionability dimension of the 
scale. The poor rating on actionability of health materials is a common finding as they often fail 
to pay attention to the clarity of instructions and actions for people/patients to follow,6,43 it 
may also reflect the fact that some PtDAs may not require clear actions or next steps. The 
discrepancy between more simple but objective measures of readability versus more 
sophisticated but subjective ratings of comprehension are not unexpected. However, efforts to 
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overcome subjectivity in PEMAT are addressed by the use of two or more raters. This measure 
also correlates with readability scores and patient reported comprehension and actionability 
rating and has the advantage of including an audiovisual dimension.14 In total our results 
suggest there is room for significant improvement in the design and reporting of decision aids 
for lower literacy populations. 
In addition to the assessment of readability, developers of PtDAs included in our review used a 
range of strategies to tailor their PtDAs to disadvantaged patients and populations. The main 
strategies included working with patients or consumers in various ways (e.g., pilot or user 
testing and focus groups or interviews), the involvement of adult education, communication, or 
literacy experts, and the use of PtDA formats other than text (e.g., video or multimedia 
programs). Note few studies reported including patients as partners. It is important as research 
goes forward that patients are included as equal partners in research and that pilot testing (and 
other forms of tailoring / gathering feedback) is conducted and clearly reported with patients / 
consumers from the target disadvantaged groups. This was often not made clear in the 
included studies.  
Our review of the impact of the PtDAs showed reasons to be cautiously optimistic. Outcomes 
pooled in our meta-analysis suggested many improvements as a result of viewing a PtDA. These 
improvements included increased knowledge and patient-clinician communication, as well as 
reductions in decisional conflict and proportion undecided. Notably, studies that used the low-
literacy version of the Decisional Conflict Scale reported greater decreases in decisional conflict. 
However, this result should be interpreted with caution given the high heterogeneity 
comparative to the summary estimate of studies using the original scale. Despite high 
heterogeneity for many pooled outcomes, the direction of effects was consistent across 
included studies. In the narrative synthesis, we found three of three studies reported increased 
accuracy in risk perceptions and two reported greater congruence between attitudes and 
choice and more informed choices (adequate knowledge and congruent attitudes and choice). 
There were no effects of PtDAs evident on decision satisfaction, adherence to chosen option or 
health outcomes including anxiety, regret and confidence. Mixed effects were evident for 
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decision-making process satisfaction, participation in decision, attitudes, 
preferences/intentions and behavioral outcomes. Outcomes relating to health, wellbeing and 
the healthcare system were seldom measured in the included studies (i.e., health status and 
quality of life, depression, emotional distress, costs, cost-effectiveness, consultation length, 
litigation rates). Overall, our narrative synthesis of outcomes in studies that conducted separate 
analyses suggested some PtDAs were more beneficial among disadvantaged groups (e.g., by 
race, ethnicity, education, health literacy, lack of insurance). However, effects for outcomes 
across types of disadvantage were inconsistent across the different contexts of included 
studies. Encouragingly, many studies included in the narrative synthesis had similar effects for 
outcomes analyzed across disadvantaged and non-disadvantaged groups. 
 
Strengths and limitations of this review 
To assess readability of the PtDAs, we followed guidelines from Health Literacy Connections.44 
This included preparing the text as detailed in the methods and calculating the estimated 
reading grade level using the average of the Gunning Fog index and the SMOG index. Several 
included studies reported designing the PtDA at reduced reading grade level and calculating 
readability statistics of PtDAs in the development process. For many of these PtDAs, there are 
notable discrepancies between the readability statistics reported in the studies and those we 
calculated in table 6. This could be explained by factors including variations in the preparation 
of the text (e.g., removing headings, periods that do not indicate end of sentences, sentence 
fragments, bullet points not in full text), readability formula used (e.g., Flesch Kinkaid Grade 
Level has been reported to produce reading grade levels 2-3 lower),45 method of conducting 
the analysis (e.g., using an online tool, Microsoft word function or calculating manually using 
the formula). Due to the subjective nature of the PEMAT, the PtDAs were dual coded by JS and 
OM, with any discrepancies resolved with discussion with KM. The actionability domain of the 
PEMAT is limited in this context, as there may not always be an explicit action to take. 
Furthermore, for two studies we were only able to access a component of the intervention, 
which may limit the accuracy of the actionability scores.   
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We built on and strengthened our previous review by including 25 RCTs and including a 
systematic review of decision related outcomes as well as an assessment of the attention paid 
to health literate design. Given the larger number of studies, we were able to conduct a meta-
analysis for common and consistently measured outcomes. Despite high levels of 
heterogeneity, we did not assess the source given that we anticipated high levels due to the 
nature of included studies and variable contexts and outcomes. However, results should be 
interpreted in light of this limitation. We also used the new version of the Cochrane Risk of Bias 
tool and conducted screening and risk of bias assessments with two independent reviewers. 
Data was extracted independently by two reviewers. Where necessary to attain unreported 
data, we made efforts to contact authors, included values reported in 2014 and 2017 Cochrane 
reviews, or used the Cochrane calculator where appropriate.  
Alternative formats for decision support, such as Option Grids,46 have also been developed 
which generally have less textual information compared to typical decision aids and are 
designed to be used jointly with a provider within an encounter. We did not consider the 
studies that included older adults (that did not report any other measures of disadvantage) 
despite the fact that this population may comprise a greater proportion of people with low 
health literacy skills compared to the general population. 
Recommendations to IPDAS 
On the basis of our review we make the following recommendations for consideration in future 
IPDAS criteria related to health literacy: 
- all PtDAs report readability scores and in addition use and adhere to PEMAT thresholds for 
comprehension and actionability of written and audiovisual documents. 
- readability scores are assessed using utility.com and suggest where possible PtDA 
developers develop tools at reading grade level 5/6 consistent with a Universal Precautions 
approach and the AHRQ Health Literacy Universal Precautions Toolkit.47 
- patient partners are included in all studies with low literacy populations 
- studies that target disadvantaged populations must report how PtDAs have been piloted 
with their target group to ensure needs and preferences are addressed. 
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- In line with good principles of health communication we recommend the use of 
audiovisual, audio as well as written health information and the provision of translated 
materials. 
Directions for future research 
There is a need for greater consistency in the measurement of outcomes, particularly relating 
to attributes of the decision and decisional conflict (e.g., the low literacy DCS is not always 
used). Greater consistency in the use and reporting of sub-analyses is also needed to ensure 
PtDAs are suitable and beneficial for disadvantaged groups, and outcomes can be synthesized 
in future reviews. A few studies (mostly more recent) examined the impact of the PtDA on 
patient-clinician communication.18,19,37,38 More research in this vein would be valuable to better 
understand the impact of PtDAs on the clinical encounter among disadvantaged groups. A few 
studies examined longer term outcomes, but this was rare – further work to understand if 
knowledge improvements and decisional conflict outcomes are maintained would also be 
valuable. Last, little research has addressed how disadvantaged populations best access PtDAs. 
This is vitally important if we truly wish to improve equity with respect to accessing decision 
support. 
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Attitudes towards and acceptability of PtDAs 
Volk et al. tested the moderating effects of literacy level on the acceptability of two prostate 
cancer screening PtDAs.27 Compared to those with high literacy, low literacy participants 
were more likely to rate the entertainment aid as having too much information, but also less 
likely to rate it as too long and were more likely to ask questions overall. Low literacy 
participants rated the clarity of the audio-booklet higher than the entertainment aid but 
were more engaged with elements of the entertainment aid. Kuppermann et al. tested the 
moderating effects of education on intervention satisfaction. They found that all women 
were more likely to say they would recommend the PtDA to a friend, but the increase was 
more pronounced among women with a bachelor’s or graduate degree.16  
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Table 1. PEMAT scoring 
Item # PEMAT items 
‘Agree’ 
responses n (%) 
 Understandability   
 Content  
1 Makes its purpose completely evident (P and A/V) 12 (100) 
2 Does not include information or content that distracts from its 
purpose (P) 
7 (100) 
 Word Choice and style  
3 Common everyday language (P and A/V) 12 (100) 
4 Medical terms are defined and used only to familiarise readers (P and 
A/V) 
12 (100) 
5 Active voice (P and A/V) 12 (100) 
 Use of numbers   
6 Numbers are clear and easy to understand (P) 7 (100) 
7 Does not expect the user to perform calculations (P) 7 (100) 
 Organization   
8 Chunks information into short sections (P and A/V) 10 (83) 
9 Sections have informative headings (P and A/V) 8 (67) 
10 Presents information in a logical sequence (P and A/V) 12 (100) 
11 Provides a summary  (P and A/V)  
 Layout and design  
12 Provides visual cues to draw attention to key points (P and A/V) 10 (83) 
13 Text on the screen is easy to read (A/V)* 4 (100) 
14 The material allows the user to hear the words clearly (A/V) 5 (100) 
 Use of visual aids  
15 Uses visual aids whenever possible (P) 3 (43) 
16 Visual aids reinforce rather than distract (P) 7 (100) 
17 Visual aids have clear titles and captions (P) 6 (86) 
18 The material uses illustrations and photographs that are clear and 
uncluttered (P and A/V)* 
11 (100) 
19 Tables are simple with short, clear row and column headings (P and 
A/V) 
4 (100)^ 
 Actionability   
20 Clearly identifies at least one action for the user to take (P and A/V) 12 (100) 
21 Addresses the user directly when describing actions (P and A/V) 11 (92) 
22 Breaks down actions into manageable, explicit steps (P and A/V) 8 (67) 
23 Provides a tangible tool whenever it could help the user take action (P 
and A/V) 
7 (100) 
24 Provides simple instructions or examples of how to perform 
calculations (P)# 
- 
25 Explains how to use the charts, diagrams, graphs, or tables to take 
actions (P and A/V)~ 
3 (33) 
26 Uses visual aids whenever possible to help take action (P) 1 (14) 
*N/A for 1 PtDA, ^N/A for 8 PtDAs, #N/A for all PtDAs, ~N/A for 3 PtDAs 
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Table 2. Risk of bias summary for each included study not included in 2014/17 Cochrane 
review 





















































































Boulware et al 2018 + ? ? + ? ? 
Brenner et al 2016 + - + ? + ? 
Diefenbach et al 2018 + ? ? ? ? ? 
Hoffman et al 2017 + ? + ? + + 
Ibrahim et al 2017 + ? + + + + 
Jimenez et al 2017 ? ? + ? ? ? 
Miller et al 2018 + ? + + ? + 
Rising et al 2017 + ? + + + + 
Vina et al 2016 + + + + ? + 






Table 3. Risk of bias summary for each included study in 2014 and 2017 Cochrane review 










































































































































































Jibaja-Weiss et al 2011* + ? ? + ? ? + 
Kuppermann et al 2009^ ? + + + ? ? + 
Kuppermann et al 2014* + + + + + + + 
Lepore et al 2012* + ? ? + + + + 
Marteau et al 2010* + + + + + + + 
Miller et al 2011* + ? + + + + ? 
Myers et al 2005^ ? ? + ? ? ? + 
Ruffin et al 2007* + ? + + + ? + 
Schroy et al 2011* ? ? ? + + ? + 
Smith et al 2010* + + + + + + + 
Street et al 1995^ ? ? ? ? + ? + 
Taylor et al 2006* ? ? ? ? + ? ? 
Trevena et al 2008* + + ? + ? + + 
Volk et al 2008^ + ? ? ? ? ? + 
Williams et al 2013* ? ? ? ? + ? + 
Wolf et al 1996* ? ? ? + + ? + 
+ low risk of bias, ? unclear risk of bias, - high risk of bias 
*Risk of bias assessed as part of 2017 version of Cochrane Review 




Figure 1. Funnel plots for each outcome included in meta-analysis. 
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Patient-clinician communication 
